Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in patients from southern Poland.


BACKGROUND Hypertrophic cardiomyopathy (HCM) is a genetic disease. The role of phospholamban (PLN) gene mutations is the development of HCM has not been established. AIM To screen for PLN gene mutations in a group of HCM patients from the southern Poland. METHODS We included 50 consecutive patients (31 males, mean age 42 ± 14 years) diagnosed with HCM… (More)


  • Presentations referencing similar topics